These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33459229)

  • 81. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
    Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J
    Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237
    [TBL] [Abstract][Full Text] [Related]  

  • 82. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation.
    Resende R; Ferreiro E; Pereira C; Oliveira CR
    J Neurosci Res; 2008 Jul; 86(9):2091-9. PubMed ID: 18335524
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Overcoming cell death and tau phosphorylation mediated by PI3K-inhibition: a cell assay to measure neuroprotection.
    Simon D; Medina M; Avila J; Wandosell F
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):208-14. PubMed ID: 21222634
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain.
    Pei JJ; Tanaka T; Tung YC; Braak E; Iqbal K; Grundke-Iqbal I
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):70-8. PubMed ID: 8990130
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.
    Mercado-Gómez O; Hernández-Fonseca K; Villavicencio-Queijeiro A; Massieu L; Chimal-Monroy J; Arias C
    Neurochem Res; 2008 Aug; 33(8):1599-609. PubMed ID: 18461448
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
    Liang Z; Li QX
    ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
    [TBL] [Abstract][Full Text] [Related]  

  • 87. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.
    Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q
    J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mori Fructus improves cognitive and neuronal dysfunction induced by beta-amyloid toxicity through the GSK-3β pathway in vitro and in vivo.
    Kim HG; Park G; Lim S; Park H; Choi JG; Jeong HU; Kang MS; Lee MK; Oh MS
    J Ethnopharmacol; 2015 Aug; 171():196-204. PubMed ID: 26068423
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
    Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
    CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Kororamides, Convolutamines, and Indole Derivatives as Possible Tau and Dual-Specificity Kinase Inhibitors for Alzheimer's Disease: A Computational Study.
    Llorach-Pares L; Nonell-Canals A; Avila C; Sanchez-Martinez M
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30332805
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
    Hu M; Waring JF; Gopalakrishnan M; Li J
    J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
    [TBL] [Abstract][Full Text] [Related]  

  • 94. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP; Hughes K; Woodgett JR; Brion JP; Anderton BH
    Neurosci Lett; 1992 Nov; 147(1):58-62. PubMed ID: 1336152
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
    Mazumder MK; Choudhury S
    Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

  • 99. GSK-3: a key player in neurodegeneration and memory.
    Giese KP
    IUBMB Life; 2009 May; 61(5):516-21. PubMed ID: 19391164
    [TBL] [Abstract][Full Text] [Related]  

  • 100. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
    Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
    Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.